Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Bupivacaine for Pain Control After Sternotomy
NCT04585867Phase 1Unknown
- Sponsor
- University of Kansas Medical Center
- Start
- Oct 2017
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by University of Kansas Medical Center. Primary endpoint: Opioid consumption in morphine equivalents at 0 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04585867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585867.